Email not displaying correctly? View it in your browser
manifesto

The Lancet : A Study shows ASMQ has the highest cure rate for treating Malaria in Myanmar

A study led by F. Smithuis (MSF) and N. White (Mahidol University, Bangkok) comparing all current available fixed dose combination (FDC) treatments for uncomplicated Plasmodium falciparum malaria concluded that artesunate-mefloquine, arthemether-lumefantrine and dihydroartemisinin-piperquine were highly effective. ASMQ FDC developed by DNDi and Farmanguinhos had the highest cure rates.
Read more

The Lancet: Champion of neglected diseases

The Lancet has published a profile of Bernard Pécoul, Executive Director of DNDi. The article "Championing the cause of neglected diseases" describes Bernard Pécoul's background, career, and motivation as well as DNDi's mission, goals, and achievements.
Read more

Past event: ICOPA XII, August 15 - 20, 2010, Melbourne

DNDi participated in the XIIth International Congress of Parasitology (ICOPA) 2010 and organised two symposia (on Malaria and on Drug Discovery), as well as a preview of the documentary "1$ for 1 life". The documents and presentations of these events can be found on the DNDi website. Read More
 

DNDi supports a clinical trial for the treatment of Visceral Leishmaniasis in Brazil

DNDi with the Ministry of Health and other partners supports a clinical study to evaluate the safety and efficacy of the combination of Ambisome + Glucantine for the treatment of Visceral Leishmaniasis in Brazil.
Read more